A detailed history of Simplify Asset Management Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, Simplify Asset Management Inc. holds 9,691 shares of LIVN stock, worth $524,283. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,691
Previous 8,905 8.83%
Holding current value
$524,283
Previous $400,000 26.75%
% of portfolio
0.03%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$41.13 - $58.72 $32,328 - $46,153
786 Added 8.83%
9,691 $507,000
Q2 2025

Aug 07, 2025

SELL
$33.85 - $47.6 $18,312 - $25,751
-541 Reduced 5.73%
8,905 $400,000
Q1 2025

May 13, 2025

BUY
$37.02 - $50.73 $1,813 - $2,485
49 Added 0.52%
9,446 $371,000
Q4 2024

Feb 11, 2025

SELL
$45.7 - $53.85 $226,169 - $266,503
-4,949 Reduced 34.5%
9,397 $435,000
Q3 2024

Nov 06, 2024

BUY
$43.38 - $54.59 $250,823 - $315,639
5,782 Added 67.52%
14,346 $753,000
Q2 2024

Aug 12, 2024

SELL
$51.76 - $64.15 $2,536 - $3,143
-49 Reduced 0.57%
8,564 $469,000
Q1 2024

May 13, 2024

BUY
$48.6 - $57.12 $223,851 - $263,094
4,606 Added 114.95%
8,613 $481,000
Q4 2023

Feb 12, 2024

SELL
$43.45 - $53.66 $12,774 - $15,776
-294 Reduced 6.84%
4,007 $207,000
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $2,455 - $2,884
-49 Reduced 1.13%
4,301 $227,000
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $183,918 - $223,720
4,350 New
4,350 $223,000
Q4 2022

Feb 10, 2023

BUY
$43.88 - $56.16 $186,577 - $238,792
4,252 New
4,252 $236,000
Q2 2022

Aug 11, 2022

SELL
$57.25 - $86.63 $386,208 - $584,405
-6,746 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$71.02 - $86.99 $26,845 - $32,882
-378 Reduced 5.31%
6,746 $552,000
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $546,553 - $660,252
7,124 New
7,124 $623,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.9B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.